Skip to main content
SpringerLink
Log in

Splenectomy for Haematological Disorders

  • Chapter
  • First Online:
GI Surgery Annual

Part of the book series: GI Surgery Annual ((GISA,volume 23))

  • 626 Accesses

Abstract

The spleen in haematological conditions is enlarged often. This leads to destruction of cell lines and especially platelets, and becomes the cause of red cell destruction and iron overload in haemolytic conditions. Massive enlargement also places the spleen at risk of injury and exsanguinating intraperitoneal haemorrhage. Rarely, it becomes so large that it restricts the daily activities of the patient. Usually a total splenectomy is done for hematological disorders. Rarely, partial splenectomy may be indicated in some metabolic conditions such as Gaucher’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623–34.

    Article  CAS  PubMed  Google Scholar 

  2. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395–403.

    Article  CAS  PubMed  Google Scholar 

  3. Forconi F, Sozzi E, Cencini E, Zaja F, Intermesoli T, Stelitano C, et al. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. Blood. 2009;114:4696–702.

    Article  CAS  PubMed  Google Scholar 

  4. Goodman GR, Bethel KJ, Saven A. Hairy cell leukemia: an update. Curr Opin Hematol. 2003;10:258–66.

    Article  PubMed  Google Scholar 

  5. Shatz DV, Romero-Steiner S, Elie CM, Holder PF, Carlone GM. Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively. J Trauma. 2002;53:1037–42.

    Article  CAS  PubMed  Google Scholar 

  6. Davies JM, Lewis MPN, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PHB. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol. 2011;155:308–17.

    Article  CAS  PubMed  Google Scholar 

  7. Sutherland CA, Burghard FF. The treatment of splenic anaemia by splenectomy. Lancet. 1910;2:1819–22.

    Article  Google Scholar 

  8. Kaznelson P. Verschwinden der hamorrhagischen diathese bei cinem falle van essenticller thrompenie (frank) nach milzexstirpation: splenogene thrombolytische purpura. Wien Klin Wochmschr. 1916;29:1451–4.

    Google Scholar 

  9. SM L, Swirsk D. The spleen and its disorders. In: Weatherall D, Ledingham JG, Warrel DA, editors. Oxford textbook of medicine, vol. 3. Oxford: Oxford University Press; 1996.

    Google Scholar 

  10. Traub A, Giebink GS, Smith C, Kuni CC, Brekke ML, Edlund D, et al. Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation. N Engl J Med. 1987;317:1559–64.

    Article  CAS  PubMed  Google Scholar 

  11. Sarangi J, Coleby M, Trivella M, Reilly S. Prevention of post splenectomy sepsis: a population based approach. J Public Health Med. 1997;19:208–12.

    Article  CAS  PubMed  Google Scholar 

  12. Zarrabi MH, Rosner F. Rarity of failure of penicillin prophylaxis to prevent postsplenectomy sepsis. Arch Intern Med. 1986;146:1207–8.

    Article  CAS  PubMed  Google Scholar 

  13. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006;81:670–5.

    Article  PubMed  Google Scholar 

  14. Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart. 2006;92:1467–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Shaw JH, Print CG. Postsplenectomy sepsis. Br J Surg. 1989;76:1074–81.

    Article  CAS  PubMed  Google Scholar 

  16. Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009;114:2861–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Taher A, Isma’eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96:488–91.

    CAS  PubMed  Google Scholar 

  18. Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008;6:1289–95.

    Article  CAS  PubMed  Google Scholar 

  19. Clarke PJ, Morris PJ. Surgery of the spleen. In: Morris PJ, Malt RA, editors. Oxford textbook of Surgery, vol. 2. Oxford: Oxford University Press; 1994.

    Google Scholar 

  20. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.

    Article  CAS  PubMed  Google Scholar 

  21. Coon WW. Splenectomy in the treatment of hemolytic anemia. Arch Surg. 1985;120:625–8.

    Article  CAS  PubMed  Google Scholar 

  22. Teo KG, Anavekar NS, Yazdabadi A, Ricketts S. Asplenic fulminant sepsis secondary to a dog bite complicated by toxic epidermal necrolysis/Stevens-Johnson syndrome. N Z Med J. 2012;125:74–7.

    PubMed  Google Scholar 

  23. Owusu-Ofori S, Hirst C. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database Syst Rev 2013;(5):CD003425. Update in: Cochrane Database Syst Rev 2015;(9):CD003425.

    Google Scholar 

  24. Najean Y, Dufour V, Rain JD, Toubert ME. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br J Haematol. 1991;79:271–6.

    Article  CAS  PubMed  Google Scholar 

  25. Fabris F, Tassan T, Ramon R, Carraro G, Randi ML, Luzzatto G, et al. Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol. 2001;112:637–40.

    Article  CAS  PubMed  Google Scholar 

  26. Auger S, Duny Y, Rossi JF, Quittet P. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis. Br J Haematol. 2012;158:386–98.

    Article  CAS  PubMed  Google Scholar 

  27. Young AE, Timothy AR. The spleen and lymphoma. In: Burnand KG, Young AE, editors. The new Aird’s companion in surgical studies. 2nd ed. London: Churchill Livingstone; 1998.

    Google Scholar 

  28. Mellemkjoer L, Olsen JH, Linet MS, Gridley G, McLaughlin JK. Cancer risk after splenectomy. Cancer. 1995;75:577–83.

    Article  CAS  PubMed  Google Scholar 

  29. Malmaeus J, Akre T, Adami HO, Hagberg H. Early postoperative course following elective splenectomy in haematological diseases: a high complication rate in patients with myeloproliferative disorders. Br J Surg. 1986;73:720–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, 110029, India

    Kamal Kataria, Naveen Kumar & Sunil Chumber

Authors
  1. Kamal Kataria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naveen Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunil Chumber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunil Chumber .

Editor information

Editors and Affiliations

  1. Department of GI Surgery and Liver Transplantation, All India Institue of Medical Sciences , New Delhi, Delhi, India

    Peush Sahni

  2. Department of GI Surgery and Liver Transplantation, All India Institute of Medical Sciences , New Delhi, Delhi, India

    Sujoy Pal

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Indian Association of Surgical Gastroenterology

About this chapter

Cite this chapter

Kataria, K., Kumar, N., Chumber, S. (2017). Splenectomy for Haematological Disorders. In: Sahni, P., Pal, S. (eds) GI Surgery Annual. GI Surgery Annual, vol 23. Springer, Singapore. https://doi.org/10.1007/978-981-10-2678-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-2678-2_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-2677-5

  • Online ISBN: 978-981-10-2678-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation